Open access · CC-BY
via OpenAlex
Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome
Angela Marie Abbatecola, Beatrice Arosio, Michele Cerasuolo, Maria Chiara Auriemma, Irene Di Meo, Elisa Langiano, Maria Rosaria Rizzo
Journal of Gerontology and Geriatrics · 2024 · ▲ 8 citations
Abstract
Aging and age-related diseases share several biological mechanisms, forming a finely controlled network where inflammation plays an encompassing key role. In the Central Nervous System (CNS), glial cells can modulate neuroinflammation by promoting neuronal homeostasis and limit neurodegeneration. However, age-related systemic inflammation (i.e. inflammaging(definition)) leads to additional deteriorations of both microglia and astrocytes causing an exacerbation response of these cells to stimuli. Type 2 diabetes (T2DM), a chronic metabolic disorder characterized by hyperglycemia, has also been associated with multiple organs loss, including the brain. Numerous studies have underlined direct correlations between diabetes, cognitive decline and dementia, however exact mechanisms related to neurodegeneration in T2DM remain to be elucidated. It widely recognized that aging is considered the most critical risk factor for Alzheimer’s disease (AD), however there are increasing data highlighting that metabolic disorders are also strongly associated with an increased risk of AD and T2DM. Indeed, impaired glucose metabolism and mitochondrial activity are common grounds for cognitive dysfunction and AD. The Metabolic syndrome (MetS) in mid-life may accelerate the progression of AD pathogenesis by activating an increased productions neuroinflammatory biomarkers leading to amyloid pathology degeneration. There remains an intricate crosstalk between the aging process, T2DM, MetS, and neuroinflammation, thus resulting in neuronal loss and the development of cognitive impairment with an accelerated risk of AD. Future studies are needed to identify potential therapeutic benefits related to improving neuroinflammation on cognitive performance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.36150/2499-6564-n691
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Abbatecola, A.M., Arosio, B., Cerasuolo, M., Auriemma, M.C., Meo, I.D., Langiano, E., & Rizzo, M.R. (2024). Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome. <em>Journal of Gerontology and Geriatrics</em>. https://doi.org/10.36150/2499-6564-n691
Vancouver
Abbatecola AM, Arosio B, Cerasuolo M, Auriemma MC, Meo ID, Langiano E, et al. Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome. Journal of Gerontology and Geriatrics. 2024. doi:10.36150/2499-6564-n691.
BibTeX
@article{angela2024Common,
title = {Common neurodegenerative pathways in brain aging, cognitive decline, type 2 diabetes & metabolic syndrome},
author = {Angela Marie Abbatecola and Beatrice Arosio and Michele Cerasuolo and Maria Chiara Auriemma and Irene Di Meo and Elisa Langiano and Maria Rosaria Rizzo},
journal = {Journal of Gerontology and Geriatrics},
year = {2024},
doi = {10.36150/2499-6564-n691},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular neurobiology 2026
Citation only
Soluble TREM1 Contributes to Aging-Related Neurodegeneration via ROBO2/ERK Pathway.
Ningbo No. 1 Hospital 2025
Open access · US-GOV
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population: a Cohort Study
Circulation 2005
Citation only
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Neural Regeneration Research 2020
Open access · CC-BY
Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease
European Journal of Neuroscience 2011
Citation only
Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype
Ecotoxicology and environmental safety 2026
Citation only